(Q53633285)

16 May 2018

title

Quality of life evaluation by the EORTC questionnaire technique in patients with generalized malignant melanoma on chemotherapy. (English)

1 reference

16 May 2018

1 reference

1 reference

1 reference

Sigurdardóttir V

1

1 reference

16 May 2018

Bolund C

series ordinal

2

1 reference

16 May 2018

Sullivan M

series ordinal

3

1 reference

16 May 2018

publication date

1 January 1996

1 reference

16 May 2018

published in

Acta Oncologica

1 reference

16 May 2018

volume

35

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

149-158

1 reference

16 May 2018

Trends in survival from malignant melanoma: remarkable improvement in 23 years

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

The quality of life of cancer patients: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

Quality of life research in oncology. Past achievements and future priorities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

Comparative studies of psychological function in patients with advanced cancer. II. Interviewer-rated current and past psychological symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869609098495

10.3109/02841869609098495

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018